Akèy › Kansè Metastatik › Washington › Tacoma
Etid klinik pou Kansè Metastatik nan Tacoma, WA
9 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Tacoma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- Providence Regional Cancer System-Lacey, Lacey · 23 mi lwen
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Ap rekriteFaz 3
- Research Site, Puyallup · 8 mi lwen
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · 8 mi lwen
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi lwen
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Ap rekriteFaz 3
- Research Site, Tacoma
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- MultiCare Health System, Tacoma
SLV-154 Treatment of Advanced Cancers
Ap rekriteFaz 1
- Northwest Medical Specialties, PLLC, Tacoma
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Ap rekriteFaz 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · 8 mi lwen
- MultiCare Regional Cancer Center, Puyallup · 8 mi lwen
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Ap rekriteFaz 1/2
- Northwest Medical Specialties, PLLC, Tacoma
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Ap rekriteFaz 1
- Northwest Medical Specialties, Tacoma
Etid Kansè Metastatik nan lòt vil
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
Lòt etid nan Tacoma
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete18 etid
- Kolit Ulseratif15 etid
- Myelom Miltip13 etid
- Kansè pwostat11 etid
- Maladi Crohn11 etid
- Kansè kolorektal9 etid
- Melanom7 etid
- Kansè ovè7 etid
- Kansè (tout kalite)6 etid
- Kansè pankreyas6 etid
- Obèsite6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.